These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 7898563

  • 1. Glucose and insulin metabolism in patients with hyperthyroidism due to Graves' disease.
    Mano T, Kawakubo A, Yamamoto M.
    Nagoya J Med Sci; 1994 Mar; 57(1-4):61-8. PubMed ID: 7898563
    [Abstract] [Full Text] [Related]

  • 2. [Blood glucose and insulin responses to oral glucose in hyperthyroidism].
    Pandolfi C, Pellegrini L, Dedè A.
    Minerva Endocrinol; 1996 Jun; 21(2):63-5. PubMed ID: 9026683
    [Abstract] [Full Text] [Related]

  • 3. [Dynamics of blood glucose, serum insulin and lipids during the oral glucose tolerance test in hyperthyroidism].
    Khlebarova M, Tsanev A, Zlateva S, Dishlianova B, Tŭrkolev N.
    Vutr Boles; 1985 Jun; 24(3):98-104. PubMed ID: 3895747
    [Abstract] [Full Text] [Related]

  • 4. Plasma glucose, insulin, proinsulin, C-peptide and glucagon before and after a carbohydrate-rich meal in hyperthyroid patients.
    Rovira A, Valdivielso L, Ortega R, Valverde I, Herrera Pombo JL.
    Diabete Metab; 1987 Jun; 13(4):431-5. PubMed ID: 3315763
    [Abstract] [Full Text] [Related]

  • 5. Factors predicting the course of diabetes mellitus in hyperthyroid patients.
    Hamada N, Ito K, Mimura T, Momotani N, Nishikawa Y, Fujii S, Morii H, Wada M.
    Horm Metab Res; 1986 Apr; 18(4):260-3. PubMed ID: 3519414
    [Abstract] [Full Text] [Related]

  • 6. Effects of propranolol and hemodialysis on the response of glucose, insulin, C-peptide and cyclic AMP to glucagon challenge.
    Pun KK, Yeung CK, Ho PW, Lin HJ, Chan MK, Yeung RT.
    Clin Nephrol; 1984 Apr; 21(4):235-40. PubMed ID: 6329569
    [Abstract] [Full Text] [Related]

  • 7. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
    Gragnoli G, Tanganelli I, Signorini AM.
    Boll Soc Ital Biol Sper; 1980 Jan 15; 56(1):69-75. PubMed ID: 7002168
    [Abstract] [Full Text] [Related]

  • 8. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.
    Abdul-Ghani MA, Williams K, DeFronzo R, Stern M.
    Diabetes Care; 2006 Jul 15; 29(7):1613-8. PubMed ID: 16801587
    [Abstract] [Full Text] [Related]

  • 9. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N, Hara K, Yatsuka C, Nakano T, Matsumoto S, Suetsugu M, Nakamachi T, Takebayashi K, Inukai T, Haruki K, Aso Y.
    Metabolism; 2009 Oct 15; 58(10):1470-6. PubMed ID: 19592051
    [Abstract] [Full Text] [Related]

  • 10. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N.
    Eur J Med Res; 2003 Jul 31; 8(7):295-303. PubMed ID: 12911866
    [Abstract] [Full Text] [Related]

  • 11. Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance.
    Muscelli E, Mari A, Natali A, Astiarraga BD, Camastra S, Frascerra S, Holst JJ, Ferrannini E.
    Am J Physiol Endocrinol Metab; 2006 Dec 31; 291(6):E1144-50. PubMed ID: 16478775
    [Abstract] [Full Text] [Related]

  • 12. Methylprednisolone increases plasma leptin levels in Graves' hyperthyroidism patients with active Graves' ophthalmopathy.
    Song YM, Lee WJ, Chen MD, Kao CH, Sheu WH.
    Horm Metab Res; 2000 Jul 31; 32(7):277-82. PubMed ID: 10965934
    [Abstract] [Full Text] [Related]

  • 13. Enhanced glucose-dependent glucagon-like peptide-1 and insulin secretion in Crohn patients with terminal ileum disease is unrelated to disease activity or ileal resection.
    Bendet N, Scapa E, Cohen O, Bloch O, Aharoni D, Ramot Y, Weiss M, Halevi A, Rapoport MJ.
    Scand J Gastroenterol; 2004 Jul 31; 39(7):650-6. PubMed ID: 15370686
    [Abstract] [Full Text] [Related]

  • 14. Increased blood proinsulin and decreased C-peptide levels in patients with pancreatic cancer.
    Nakamori S, Ishikawa O, Ohigashi H, Sasakuma F, Shimizu T, Nakaizumi A, Furukawa H, Sasaki Y, Imaoka S.
    Hepatogastroenterology; 1999 Jul 31; 46(25):16-24. PubMed ID: 10228759
    [Abstract] [Full Text] [Related]

  • 15. [Radioimmunologic analysis of insulin (IRI) in glucose metabolism in uremic patients].
    Martino F, Baviera G, Bonanno N, Purello D'Ambrosio F.
    Riv Eur Sci Med Farmacol; 1989 Aug 31; 11(4):329-39. PubMed ID: 2701029
    [Abstract] [Full Text] [Related]

  • 16. Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes.
    Hiroyoshi M, Tateishi K, Yasunami Y, Maeshiro K, Ono J, Matsuoka Y, Ikeda S.
    Am J Gastroenterol; 1999 Apr 31; 94(4):976-81. PubMed ID: 10201468
    [Abstract] [Full Text] [Related]

  • 17. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z.
    Neuro Endocrinol Lett; 2007 Dec 31; 28(6):807-10. PubMed ID: 18063948
    [Abstract] [Full Text] [Related]

  • 18. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
    Miyazaki Y, DeFronzo RA.
    Diabetes Obes Metab; 2008 Dec 31; 10(12):1204-11. PubMed ID: 18476983
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.